Cell Death Discovery (Aug 2022)

Human-specific gene CT47 blocks PRMT5 degradation to lead to meiosis arrest

  • Chao Li,
  • Yuming Feng,
  • Zhenxin Fu,
  • Junjie Deng,
  • Yue Gu,
  • Hanben Wang,
  • Xin Wu,
  • Zhengyun Huang,
  • Yichen Zhu,
  • Zhiwei Liu,
  • Moli Huang,
  • Tao Wang,
  • Shijun Hu,
  • Bing Yao,
  • Yizhun Zeng,
  • Chengji J. Zhou,
  • Steve D. M. Brown,
  • Yi Liu,
  • Antonio Vidal-Puig,
  • Yingying Dong,
  • Ying Xu

DOI
https://doi.org/10.1038/s41420-022-01139-6
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Exploring the functions of human-specific genes (HSGs) is challenging due to the lack of a tractable genetic model system. Testosterone is essential for maintaining human spermatogenesis and fertility, but the underlying mechanism is unclear. Here, we identified Cancer/Testis Antigen gene family 47 (CT47) as an essential regulator of human-specific spermatogenesis by stabilizing arginine methyltransferase 5 (PRMT5). A humanized mouse model revealed that CT47 functions to arrest spermatogenesis by interacting with and regulating CT47/PRMT5 accumulation in the nucleus during the leptotene/zygotene-to-pachytene transition of meiosis. We demonstrate that testosterone induces nuclear depletion of CT47/PRMT5 and rescues leptotene-arrested spermatocyte progression in humanized testes. Loss of CT47 in human embryonic stem cells (hESCs) by CRISPR/Cas9 led to an increase in haploid cells but blocked the testosterone-induced increase in haploid cells when hESCs were differentiated into haploid spermatogenic cells. Moreover, CT47 levels were decreased in nonobstructive azoospermia. Together, these results established CT47 as a crucial regulator of human spermatogenesis by preventing meiosis initiation before the testosterone surge.